Epstein Secrets

lucose, Urine NEGATIVE NEGATIVE Ketone, Urine NEGATIVE NEGATIVE Urobilinogen Urine 0.2 0.2 - 1.0 mg/dL sioReference Laboratories, Inc. 481 Edward H. Ross Dr I Elmwood Park, N3 07407 I (800) 2: lames Weisberger, M.D. Clinical Page 2 of 6 9-5227 Laboratory Director Printed 07/25/2016 07:01 g abed 4£9

f the presence or absence of malignant disease. ASSAY INFORMATION: Method Electrochemiluminescence Immunoassay (Roche Diagnostics) PSA, FREE TNP Not Estab. ng/mL Test Not Performed: Specimen rejected for testing due to moderate or marked hemolysis. 0.70 101/27/2016 NOTE: Results cannot be interpre

rol 13 Evaluation: ABOVE AVG.(MDDERATE RISK) >14 K 17 01/27/2016 Chol/HDL Ratio 7.5 <7.4 I 6.0 101/27/2016 BioReference Laborator1e 481 Edward H. Ross Dr James meisberger, Laboratory Director Clinical Page 1 of 6 Printed 07/25/2016 07:01 abed VE91986Z12l. iPsH AsJeH WALE:GO 9102 60 6NV EFTA002829

th different assay methods or kits cannot be interchangeably. ASSAY INFORMATION: Method Electrochemiluminescence Immunoassay (Roche Diagnostics). Not Estab. ng/mL to moderate or marked of the obtained used I 0.33 ¶01/27/2016 % FREE PSA TNP FREE PSA RISK ASSESSMENT The probability of prostate

13 Evaluation: ABOVE AV6.(MODERATE RISK) >14 X 17 01/27/2016 Chol/HDL Ratio 7.5 <7.4 6.0 01/27/2016 BioReference Laboratories, Inc. 481 Edward H. Ross Dr Elmwood Park, N7 07407 I (800) 2 9-5227 lames 4eisberger, Laboratory Director Clinical Page 1 of 6 Printed 07/25/2016 07:01 p gad b£91.886ZLZ1

th different assay methods or kits cannot be interchangeably. ASSAY INFORMATION: Method Electrocheedluninescence Immunoassay (Roche Diagnostics). Not Estab. ng/mi. to moderate or marked of the obtained used 1 0.33 101/27/2016 % FREE PSA TNP FREE PSA RISK ASSESSMENT The probability of prostate